Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility
- PMID: 30349323
- PMCID: PMC6183553
- DOI: 10.2147/IDR.S173805
Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility
Abstract
Purpose: In this study, we report results from a 5-year surveillance for noncandidal yeast species causing invasive infections from 65 hospitals in China.
Materials and methods: Species identification was carried out by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS) supplemented by rDNA sequencing, and fluconazole and voriconazole susceptibilities of yeasts were determined by Clinical and Laboratory Standards Institute (CLSI) disk diffusion methods.
Results: Overall, 884 noncandidal isolates belonging to 38 species were collected. Cryptococcus neoformans was the most common (75.6%), which also comprised 96.5% of the isolates from cerebrospinal fluid (CSF) and 62.6% from blood, followed by Trichosporon asahii (6.9%) and Rhodotorula mucilaginosa (5.1%). Fluconazole susceptibility and resistant rates were 74.1% and 9.7% for C. neoformans and 81.0% and 5.2% for T. asahii. Voriconazole exhibited good activity in comparison to these two species (99.5% and 98.3% of the isolates, were susceptible). However, 100% of the R. mucilaginosa isolates were resistant to both azoles. Other noncandidal yeast species showed reduced susceptibility to fluconazole (53.3%) but most were susceptible to voriconazole (94.3%). Over the 5 years, a decrease in the proportion of fluconazole-susceptible isolates was observed for C. neoformans (90%-67%, P<0.001) and other noncandidal yeast species (91%-66%, P<0.001). Moreover, the prevalence of azole-resistant R. mucilaginosa increased from 1% to 7% (P<0.001).
Conclusion: The shift in azole susceptibilities in mainland China calls for continued surveillance for noncandidal yeasts.
Keywords: China; azole susceptibility; epidemiology; invasive fungal infections; noncandidal yeasts.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures


Similar articles
-
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.J Clin Microbiol. 2009 Jan;47(1):117-23. doi: 10.1128/JCM.01747-08. Epub 2008 Nov 12. J Clin Microbiol. 2009. PMID: 19005141 Free PMC article.
-
Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study.J Clin Microbiol. 2018 Jun 25;56(7):e00577-18. doi: 10.1128/JCM.00577-18. Print 2018 Jul. J Clin Microbiol. 2018. PMID: 29743305 Free PMC article.
-
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.J Clin Microbiol. 2012 Dec;50(12):3952-9. doi: 10.1128/JCM.01130-12. Epub 2012 Oct 3. J Clin Microbiol. 2012. PMID: 23035204 Free PMC article.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.Dan Med J. 2016 Oct;63(10):B5288. Dan Med J. 2016. PMID: 27697142 Review.
Cited by
-
All You Need To Know and More about the Diagnosis and Management of Rare Yeast Infections.mBio. 2021 Aug 31;12(4):e0159421. doi: 10.1128/mBio.01594-21. Epub 2021 Aug 24. mBio. 2021. PMID: 34425700 Free PMC article.
-
Epidemiology And Antifungal Susceptibility Patterns Of Invasive Fungal Infections From 2012 To 2014 In A Teaching Hospital In Central China.Infect Drug Resist. 2019 Nov 22;12:3641-3651. doi: 10.2147/IDR.S227839. eCollection 2019. Infect Drug Resist. 2019. PMID: 31819547 Free PMC article.
-
Cryptococcosis in Patients following Kidney Transplantation: A 9-Year Retrospective Clinical Analysis at a Chinese Tertiary Hospital.Biomed Res Int. 2019 Nov 11;2019:7165160. doi: 10.1155/2019/7165160. eCollection 2019. Biomed Res Int. 2019. PMID: 31828122 Free PMC article.
-
Candidiasis and Other Emerging Yeasts.Curr Fungal Infect Rep. 2023;17(1):15-24. doi: 10.1007/s12281-023-00455-3. Epub 2023 Jan 31. Curr Fungal Infect Rep. 2023. PMID: 36741271 Free PMC article. Review.
-
Molecular typing and antifungal drug susceptivity profile of Rhodotorula mucilaginosa from canine skin and ear canal.J Vet Med Sci. 2021 Oct 5;83(10):1545-1548. doi: 10.1292/jvms.21-0361. Epub 2021 Sep 14. J Vet Med Sci. 2021. PMID: 34526416 Free PMC article.
References
-
- Miceli MH, Díaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis. 2011;11(2):142–151. - PubMed
-
- Schwartz S, Kontoyiannis DP, Harrison T, Ruhnke M. Advances in the diagnosis and treatment of fungal infections of the CNS. Lancet Neurol. 2018;17(4):362–372. - PubMed
-
- Pande A, Non LR, Romee R, Santos CAQ. Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center. Transplant Infectious Disease. 2017;19(2):e12664. - PubMed
-
- Kullberg BJ, Arendrup MC. Invasive Candidiasis. N Engl J Med. 2015;373(15):1445–1456. - PubMed
-
- Limper AH, Adenis A, Le T, Harrison TS. Fungal infections in HIV/ AIDS. Lancet Infect Dis. 2017;17(11):e334–e343. - PubMed
LinkOut - more resources
Full Text Sources